相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome With Constipation or Diarrhea: Meta-analysis
Brigida Barberio et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea
Anthony Lembo et al.
GASTROENTEROLOGY (2022)
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
Ami D. Sperber et al.
GASTROENTEROLOGY (2021)
Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Brian E. Lacy et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System
Lin Chang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis
Michelle Bosman et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study
Eric D. Shah et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis
Priya Oka et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Functional Gastrointestinal Disorders 2 Irritable bowel syndrome
Alexander C. Ford et al.
LANCET (2020)
Placebo Responses and Placebo Effects in Functional Gastrointestinal Disorders
Paul Enck et al.
FRONTIERS IN PSYCHIATRY (2020)
Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey
Sarah Ballou et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
MD-7246, a Delayed-Release Formulation of Linaclotide Targeting Visceral Pain Associated With IBS-D, Does Not Impact Bowel Frequency or Stool Consistency in Healthy Volunteers: Results From Phase I Trial
Braden Kuo et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation
Sarah Ballou et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Chronic linaclotide treatment reduces colitis-induced neuroplasticity and reverses persistent bladder dysfunction
Luke Grundy et al.
JCI INSIGHT (2018)
Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea
Jessica L. Buono et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2017)
Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research
Sheri E. Fehnel et al.
VALUE IN HEALTH (2017)
Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use
Brian E. Lacy et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
Douglas A. Drossman
GASTROENTEROLOGY (2016)
Effect of Linaclotide on Severe Abdominal Symptoms in Patients With Irritable Bowel Syndrome With Constipation
Satish S. C. Rao et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Placebo Effect in Clinical Trial Design for Irritable Bowel Syndrome
Eric Shah et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2014)
Linaclotide Inhibits Colonic Nociceptors and Relieves Abdominal Pain via Guanylate Cyclase-C and Extracellular Cyclic Guanosine 3′,5′-Monophosphate
Joel Castro et al.
GASTROENTEROLOGY (2013)
Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes
Patrick A. Hughes et al.
GUT (2013)
Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation
Robert W. Busby et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Two Randomized Trials of Linaclotide for Chronic Constipation
Anthony J. Lembo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome
A. C. Ford et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Placebo responses in patients with gastrointestinal disorders
Frauke Musial et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Defining the predictors of the placebo response in irritable bowel syndrome
M Pitz et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome
M Delvaux
GUT (2002)
分享论文
